In this announcement, readers will be able to see the table that details the lots being added to the voluntary recall, including lot product description and NDC number. 

Children and adults who inadvertently consume a higher dose of clonazepam could be at increased risk for the adverse events of significant sedation, confusion, dizziness, diminished reflexes, ataxia, and hypotonia. There is reasonable probability for significant, possibly life-threatening, respiratory depression especially for patients with concomitant pulmonary disease, patients who have prescribed dosing near maximal dosing, and patients also taking other medications that could cause additional respiratory depression.

To date, Endo, Inc. has not received any reports of adverse events associated with this product recall.

Click here to read the full announcement, including package identification, action required, and contact information.